|
|
|
|
| Introducing a new way to source solutions for improving, refining, and optimizing your CGT manufacturing! From April 8-10, Life Science Connect brings you the next virtual showcase from its network of trusted communities: Cell & Gene Therapy Tech Expo. Simply bring your attention, questions, and manufacturing requirements (no travel, cost, or inconvenience!) and experience this unique opportunity to learn about the latest technologies in CGT manufacturing and how they can help solve your biggest challenges. |
|
|
|
|
By Tyler Menichiello, contributing editor | Bioprocess Online and Cell & Gene spoke with Takeda’s Amy Shaw at BPI West to discuss the industry and her key takeaways from the conference. | |
|
|
| FDA Recommendations For Gene Therapy For PMDs | White Paper | By Kaitlyn Rouillard, Ph.D., and Rachel Ward, Ph.D., Kymanox Corporation | Explore insight into the strategies and FDA recommendations for executing gene therapy development programs, specifically for primary mitochondrial diseases (PMDs). |
|
|
|
|
|
| Optimizing Cell And Gene Therapy Workflows | e-book | Eppendorf SE | Explore the growing field of cell and gene therapies along with a bioreactor system that is enabling researchers to expedite cell culture development and optimize their research time. |
|
|
|
|
|
|
| Webinar: Future-Proofing the Material Transfer Process in Your Facility with Automated Bio-decontamination | Developers of cell and gene therapies face challenges in safely transferring living materials into closed systems without contamination or damage. A robust material transfer program requires risk assessment and modern approaches, combining manual disinfection with automated bio-decontamination. This webinar explores how automated bio-decontamination systems can enhance material transfer processes, ensuring patient safety and regulatory compliance. Click here to learn more. |
|
|
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
